{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Prostate : Questions médicales les plus fréquentes",
"headline": "Prostate : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Prostate : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-24",
"dateModified": "2025-02-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Prostate"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Glandes exocrines",
"url": "https://questionsmedicales.fr/mesh/D005088",
"about": {
"@type": "MedicalCondition",
"name": "Glandes exocrines",
"code": {
"@type": "MedicalCode",
"code": "D005088",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A10.336"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Prostate",
"alternateName": "Prostate",
"code": {
"@type": "MedicalCode",
"code": "D011467",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "A A Kamalov",
"url": "https://questionsmedicales.fr/author/A%20A%20Kamalov",
"affiliation": {
"@type": "Organization",
"name": ") Faculty of Fundamental Medicine of Lomonosov Moscow State University, Department of Urology and Andrology, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "L M Samokhodskaya",
"url": "https://questionsmedicales.fr/author/L%20M%20Samokhodskaya",
"affiliation": {
"@type": "Organization",
"name": ") Faculty of Fundamental Medicine of Lomonosov Moscow State University, Department of Urology and Andrology, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "V K Karpov",
"url": "https://questionsmedicales.fr/author/V%20K%20Karpov",
"affiliation": {
"@type": "Organization",
"name": ") Faculty of Fundamental Medicine of Lomonosov Moscow State University, Department of Urology and Andrology, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "D A Okhobotov",
"url": "https://questionsmedicales.fr/author/D%20A%20Okhobotov",
"affiliation": {
"@type": "Organization",
"name": ") Faculty of Fundamental Medicine of Lomonosov Moscow State University, Department of Urology and Andrology, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "V N Mamedov",
"url": "https://questionsmedicales.fr/author/V%20N%20Mamedov",
"affiliation": {
"@type": "Organization",
"name": ") Faculty of Fundamental Medicine of Lomonosov Moscow State University, Department of Urology and Andrology, Moscow, Russia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Prostate and metastasis-directed focal therapy in prostate cancer: hype or hope?",
"datePublished": "2023-02-03",
"url": "https://questionsmedicales.fr/article/36718727",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/14737140.2023.2171991"
}
},
{
"@type": "ScholarlyArticle",
"name": "The combined role of MRI prostate and prostate health index in improving detection of significant prostate cancer in a screening population of Chinese men.",
"datePublished": "2023-05-02",
"url": "https://questionsmedicales.fr/article/37534902",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4103/aja20239"
}
},
{
"@type": "ScholarlyArticle",
"name": "Simultaneous thulium laser resection of the prostate and transperineal prostate biopsy in clinically diagnosed metastatic prostate cancer with bladder outlet obstruction.",
"datePublished": "2023-08-18",
"url": "https://questionsmedicales.fr/article/37596454",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10103-023-03848-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Staging Prostate Cancer with",
"datePublished": "2023-04-28",
"url": "https://questionsmedicales.fr/article/37116912",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2967/jnumed.122.265371"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostate MRI Qualification:",
"datePublished": "2022-05-11",
"url": "https://questionsmedicales.fr/article/35544372",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2214/AJR.22.27615"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Tissus",
"item": "https://questionsmedicales.fr/mesh/D014024"
},
{
"@type": "ListItem",
"position": 3,
"name": "Glandes exocrines",
"item": "https://questionsmedicales.fr/mesh/D005088"
},
{
"@type": "ListItem",
"position": 4,
"name": "Prostate",
"item": "https://questionsmedicales.fr/mesh/D011467"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Prostate - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Prostate",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Prostate",
"description": "Comment diagnostiquer un cancer de la prostate ?\nQuels tests sont utilisés pour évaluer la prostate ?\nQuand faut-il faire un dépistage de la prostate ?\nQuels symptômes indiquent un problème de prostate ?\nQuel rôle joue l'examen rectal ?",
"url": "https://questionsmedicales.fr/mesh/D011467?mesh_terms=Prostatic+Neoplasms&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Prostate",
"description": "Quels sont les symptômes d'une hypertrophie bénigne de la prostate ?\nLa douleur pelvienne est-elle un symptôme courant ?\nComment reconnaître une infection de la prostate ?\nLes problèmes d'érection sont-ils liés à la prostate ?\nLe sang dans les urines est-il alarmant ?",
"url": "https://questionsmedicales.fr/mesh/D011467?mesh_terms=Prostatic+Neoplasms&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Prostate",
"description": "Peut-on prévenir le cancer de la prostate ?\nQuel rôle joue l'alimentation dans la prévention ?\nL'exercice physique aide-t-il à prévenir les problèmes de prostate ?\nLe tabagisme influence-t-il le risque de cancer de la prostate ?\nLes examens réguliers sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D011467?mesh_terms=Prostatic+Neoplasms&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Prostate",
"description": "Quels traitements existent pour le cancer de la prostate ?\nComment traiter l'hypertrophie bénigne de la prostate ?\nQu'est-ce que l'hormonothérapie ?\nLa radiothérapie est-elle efficace ?\nQuels sont les effets secondaires des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D011467?mesh_terms=Prostatic+Neoplasms&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Prostate",
"description": "Quelles sont les complications du cancer de la prostate ?\nLes traitements peuvent-ils causer des complications ?\nQuelles sont les conséquences d'une prostatite non traitée ?\nLe cancer de la prostate peut-il affecter d'autres organes ?\nComment gérer les complications après traitement ?",
"url": "https://questionsmedicales.fr/mesh/D011467?mesh_terms=Prostatic+Neoplasms&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Prostate",
"description": "Quels sont les principaux facteurs de risque du cancer de la prostate ?\nL'alimentation influence-t-elle le risque de cancer de la prostate ?\nLe surpoids est-il un facteur de risque ?\nLe niveau d'activité physique joue-t-il un rôle ?\nLes antécédents familiaux augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D011467?mesh_terms=Prostatic+Neoplasms&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un cancer de la prostate ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic se fait par un examen rectal, un dosage du PSA et une biopsie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la prostate ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'échographie, l'IRM et le dosage du PSA."
}
},
{
"@type": "Question",
"name": "Quand faut-il faire un dépistage de la prostate ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dépistage est recommandé à partir de 50 ans, ou 45 ans pour les personnes à risque."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème de prostate ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des difficultés à uriner, des douleurs pelviennes ou du sang dans les urines peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'examen rectal ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'examen rectal permet de détecter des anomalies de la prostate, comme des nodules."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une hypertrophie bénigne de la prostate ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des mictions fréquentes, un jet urinaire faible et des urgences."
}
},
{
"@type": "Question",
"name": "La douleur pelvienne est-elle un symptôme courant ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur pelvienne peut être un symptôme de prostatite ou de cancer."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une infection de la prostate ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections se manifestent par des douleurs, des mictions douloureuses et de la fièvre."
}
},
{
"@type": "Question",
"name": "Les problèmes d'érection sont-ils liés à la prostate ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles érectiles peuvent être liés à des problèmes de prostate ou à des traitements."
}
},
{
"@type": "Question",
"name": "Le sang dans les urines est-il alarmant ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la présence de sang dans les urines nécessite une évaluation médicale immédiate."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir le cancer de la prostate ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode garantie, mais un mode de vie sain peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'alimentation dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en fruits, légumes et oméga-3 peut aider à réduire le risque."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il à prévenir les problèmes de prostate ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut contribuer à maintenir une prostate en bonne santé."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le risque de cancer de la prostate ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est associé à un risque accru de développer un cancer de la prostate."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils importants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à détecter précocement des problèmes de prostate."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour le cancer de la prostate ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la radiothérapie et l'hormonothérapie."
}
},
{
"@type": "Question",
"name": "Comment traiter l'hypertrophie bénigne de la prostate ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements comprennent des médicaments, des thérapies minimales invasives et la chirurgie."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que l'hormonothérapie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hormonothérapie vise à réduire les niveaux d'hormones qui stimulent la croissance du cancer."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle efficace ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la radiothérapie est un traitement efficace pour le cancer localisé de la prostate."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des troubles urinaires, des dysfonctionnements érectiles et de la fatigue."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications du cancer de la prostate ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure la propagation du cancer, des douleurs chroniques et des problèmes urinaires."
}
},
{
"@type": "Question",
"name": "Les traitements peuvent-ils causer des complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent entraîner des effets secondaires comme des troubles urinaires et érectiles."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une prostatite non traitée ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une prostatite non traitée peut entraîner des infections récurrentes et des douleurs chroniques."
}
},
{
"@type": "Question",
"name": "Le cancer de la prostate peut-il affecter d'autres organes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le cancer peut se propager aux os, aux ganglions lymphatiques et à d'autres organes."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications après traitement ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications peut inclure des médicaments, des thérapies physiques et un suivi médical."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du cancer de la prostate ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, les antécédents familiaux et l'origine ethnique."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le risque de cancer de la prostate ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en graisses animales peut augmenter le risque de cancer."
}
},
{
"@type": "Question",
"name": "Le surpoids est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le surpoids et l'obésité sont associés à un risque accru de cancer de la prostate."
}
},
{
"@type": "Question",
"name": "Le niveau d'activité physique joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire peut augmenter le risque de développer un cancer de la prostate."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir un parent proche atteint de cancer de la prostate augmente le risque personnel."
}
}
]
}
]
}
The paradigm of focal therapy's role in metastatic patients is being challenged by evolving attitudes and emerging data. At the current time, specifically regarding prostate cancer, does the evidence ...
We searched the literature via PubMed, MEDLINE, and Embase for studies from 2014 to the present addressing focal therapy with non-palliative intent in metastatic prostate cancer patients, emphasizing ...
Current evidence is strongest, and in our opinion practice-changing, for prostate-directed RT in de novo metastatic patients with low metastatic burden. Metastasis-directed therapy with SBRT is consis...
Using prostate-specific antigen (PSA) for prostate cancer (PCa) screening led to overinvestigation and overdiagnosis of indolent PCa. We aimed to investigate the value of prostate health index (PHI) a...
Metastatic prostate cancer (mPCa) patients complicated with bladder outlet obstruction (BOO) are often referred to a urologist. Androgen deprivation therapy (ADT) combined with indwelling catheter usu...
Although prostate-specific membrane antigen (PSMA) PET/CT has been shown valuable for staging biopsy-proven [B(+)] high-risk prostate cancer, elderly patients are occasionally referred for PSMA PET/CT...
Prostate MRI is now established as a first-line investigation for individuals presenting with suspected localized or locally advanced prostate cancer. Successful delivery of the MRI-directed pathway f...
Prostate cancer has a long disease history and a wide variety and uncertainty in individual patients' clinical progress. In recent years, we have seen a revolutionary advance in both prostate cancer p...
There is a clinical need to identify patients with an elevated PSA who would benefit from prostate biopsy due to the presence of clinically significant prostate cancer (CSCaP). We have previously repo...
To further develop and adapt the MiCheck® Prostate test so it can be performed using a standard clinical chemistry analyzer and characterize its performance using the MiCheck-01 clinical trial sample ...
About 358 patient samples from the MiCheck-01 US clinical trial were used for the development of the MiCheck® Prostate test. These consisted of 46 controls, 137 non-CaP, 62 non-CSCaP, and 113 CSCaP....
Serum analyte concentrations for cellular growth factors were determined using custom-made Luminex-based R&D Systems multi-analyte kits. Analytes that can also be measured using standard chemistry ana...
Logistic regression modeling with Monte Carlo cross-validation was used to identify Human Epidydimal Protein 4 (HE4) as an analyte able to significantly improve the algorithm specificity at 95% sensit...
The MiCheck® logistic regression model was developed and consisted of PSA, %free PSA, DRE, and HE4. The model differentiated clinically significant cancer from no cancer or not-clinically significant ...
The MiCheck® Prostate test identifies clinically significant prostate cancer with high sensitivity and negative predictive value (NPV). It can be performed in a clinical laboratory using a Roche Cobas...
Prostate health index (PHI) and, more recently, Proclarix have been proposed as serum biomarkers for prostate cancer (PCa). In this study, we aimed to evaluate Proclarix and PHI for predicting clinica...
Proclarix and PHI were measured using samples of 344 men from two different centers. All patients underwent prostate biopsy, and among those, 188 men with PCa on biopsy had an additional radical prost...
The cohort median age and PSA were 65 (interquartile range [IQR]: 60-71) and 5.6 (IQR: 4.3-7.2) ng/ml, respectively. CsPCa was diagnosed in 161 (47%) men based on the RP specimen. ROC analysis showed ...
Results of this study show that both Proclarix and PHI accurately detect the presence of csPCa. The model combining Proclarix and PHI revealed the synergistic effect and improved the diagnostic perfor...
Transperineal (TP) multiparametric magnetic resonance imaging (mpMRI)-targeted biopsy (TBx) has been shown to detect more clinically significant (cs) prostate cancer (PCa) than standard template biops...
We identified all men who with suspicious lesions on mpMRI and underwent TP TBx (3-core) and concomitant SBx (20-core) in our single hospital from September 2019 to February 2021. Clinical, MRI and bi...
Three hundred and one (n = 301) men were included. The median prostate volume by MRI was 45 ml. The patients were divided by prostate volume into three groups: ≤30ml group (19.9%), >30 to ≤45 ml group...
Our data suggest that performing TBx with limited additional cores may potentially achieve the same csPCa detection rate as the combined SBx and TBx in smaller prostates....
We sought to determine whether two soluble forms with different size of mtDNA are linked to prostatic inflammation, and whether they discriminate prostate cancer (PCa) from inflammatory prostatic cond...
Histopathologically diagnosed prostatitis, PCa and benign prostatic hyperplasia patients (n = 93) were enrolled in this study and they were categorized as with and without prostate inflammation. Quant...
The urine mtDNA-79 and mtDNA-230 were significantly increased in patients with prostate inflammation compared with those in without inflammation. Here, 79-bp fragment of apoptotic origin was significa...
Our results demonstrate that shorter cf-mtDNA fragment size in particular, increase in the presence of prostate inflammation in post-prostatic massage urine but both fragments could never improve seru...